27 results on '"Keklik, Muzaffer"'
Search Results
2. AUTOLOGOUS STEM CELL TRANSPLANTATION EXPERIENCE IN B-ALL DEVELOPING DURING MAINTENANCE LENALIDOMIDE TREATMENT:CASE REPORT
3. The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study
4. POSTER: ABCL-222 Diffuse Large Cell Lymphoma of the Uterus Presented With Vaginal Bleeding: A Case Report
5. POSTER: AML-115 Acute Promyelocytic Leukemia and Stem Cell Transplantation: Case Series, Single Center Experience
6. AML-115 Acute Promyelocytic Leukemia and Stem Cell Transplantation: Case Series, Single Center Experience
7. MM-126 The Invisible Damage of the COVID-19 Pandemic to Our Apheresia Unit and the National Economy
8. ABCL-222 Diffuse Large Cell Lymphoma of the Uterus Presented With Vaginal Bleeding: A Case Report
9. Retrospective comparison of two different cell separators for autologous peripheral blood stem cell collection: Single center experience
10. CORONAVIRUS ANXIETY LEVEL AND COVID 19 VACCINE ATTITUDE AMONG HEMATOLOGICAL MALIGNANCY PATIENTS
11. EVALUATION OF COVID-19 FEAR AND QUALITY OF LIFE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE COVID-19 PANDEMIC
12. Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma
13. Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34+ peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors
14. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets
15. The evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34 + peripheral hematopoietic stem cell mobilisation for allogeneic hematopoieitic stem cell transplant donors
16. Bone marrow iron store (BMIS) as a predictive marker for survival in patients with iron overload that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)
17. Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes
18. Comparison of double dose plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC and Trima Accel cell separators
19. The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload
20. Changes in CD34+ cell count in peripheral blood after whole blood donation
21. Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: A single center experience
22. The results of therapeutic plasma exchange in patients with severe hyperthyroidism: A retrospective multicenter study
23. The management of hyperleukocytosis in an adult patient with acute lymphoblastic leukemia and ataxia-telangiectasia
24. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis
25. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study
26. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey
27. Pretransplant iron overload may be associated with increased risk of invasive fungal pneumonia (IFP) in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.